๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: Use of ursodeoxycholic acid

โœ Scribed by Young-Mee Lee; Marshall M. Kaplan

Publisher
Springer
Year
1999
Tongue
English
Weight
138 KB
Volume
1
Category
Article
ISSN
1522-8037

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

HLA DPB polymorphism in primary sclerosi
HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis
โœ James A. Underhill; Peter T. Donaldson; Derek G. Doherty; Koji Manabe; Roger Wil ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 515 KB

In recent years there has been an increasing interest in the link between susceptibility to autoimmune liver disease and genes of the HLA system, although the role of the DPBl locus in British patients has only been investigated in autoimmune hepatitis. The aim of the current study was to determine

High-dose ursodeoxycholic acid for the t
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
โœ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 319 KB ๐Ÿ‘ 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve